
Hepln-13
CAS No. 64369-13-7
Hepln-13( Hepln 13 | Hepln13 )
Catalog No. M24659 CAS No. 64369-13-7
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 115 | In Stock |
![]() ![]() |
10MG | 192 | In Stock |
![]() ![]() |
25MG | 385 | In Stock |
![]() ![]() |
50MG | 575 | In Stock |
![]() ![]() |
100MG | 801 | In Stock |
![]() ![]() |
500MG | 1647 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameHepln-13
-
NoteResearch use only, not for human use.
-
Brief DescriptionHepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
-
DescriptionHepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
-
In VitroHepln-13 (10 μM; 2 hours; 293 cells) inhibits cleavage.Western Blot Analysis Cell Line:293 cells Concentration:10 μM Incubation Time:2 hours Result:Inhibited cleavage.
-
In VivoHepIn-13 displays dose dependent inhibition of Hepsin overexpression-relevant prostate cancer phenotypes and blocks prostate cancer metastasis.
-
SynonymsHepln 13 | Hepln13
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
Recptorhepsin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64369-13-7
-
Formula Weight325.2
-
Molecular FormulaC17H13BrN2
-
Purity>98% (HPLC)
-
SolubilityDMSO:60 mg/mL?(184.50 mM;?Need ultrasonic)
-
SMILESBrc1ccc(C(N2)Nc3cccc4cccc2c34)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tang X, et al. Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget. 2014;5(5):1352-1362.
molnova catalog



related products
-
JNJ-38877605
JNJ-38877605 is a potent, selective, ATP-competitive inhibitor of catalytic activity c-Met with IC50 of 4 nM.
-
AHU377 calcium salt
AHU-377 hemicalcium salt is a potent NEP inhibitor with an IC50 of 5 nM. AHU-377 is a component of the heart failure medicine LCZ696.AHU377 is a prodrug of LBQ657.
-
Grazoprevir
MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), 0.15 nM (gt2b), respectively.